US Stock MarketDetailed Quotes
LBPS 4D pharma
- 1.650
- 0.0000.00%
Close Oct 11 09:30 ET
37.19MMarket Cap-1267P/E (TTM)
0.000High0.000Low0Volume0.000Open1.650Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)22.54MShares2.05052wk High1.15P/B27.70MFloat Cap1.50052wk Low--Dividend TTM16.79MShs Float15.500Historical High--Div YieldTTM0.00%Amplitude1.500Historical Low--Avg Price1Lot Size
About 4D pharma Company
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
Company Profile
SymbolLBPS
Company Name4D pharma
CEOMr. Duncan Joseph Peyton
MarketNASDAQ
Employees88
Securities TypeDR
ADS Ratio1.0 : 8.0
Websitehttps://www.4dpharmaplc.com
Company Executives
- Name
- Position
- Salary
- Duncan Joseph Peyton
- Executive Director,Chief Executive Officer
- 254.00K
- Dr. Alexander James Stevenson
- Executive Director,Chief Scientific Officer
- 218.00K
- John Doyle
- Chief Financial Officer
- --
- Professor Axel Gaston Glasmacher
- Non-Executive Director,Chairman
- 75.00K
- Paul Victor Maier
- Non-Executive Director
- 49.00K
- Dr. Edgardo Baracchini,PhD
- Non-Executive Director
- 50.00K
- Dr. Alexander Donald Macrae
- Non-Executive Director
- 54.00K
- Dr. Katrin Juliane Rupalla, PhD
- Non-Executive Director
- 50.00K
- Laurence Dale
- Company Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg